Skip to main content
Premium Trial:

Request an Annual Quote

All of Us Research Program: Eric Dishman

Eric Dishman, director of the National Institutes of Health's All of Us Research Program, will step down from the role and serve as the program's chief innovation officer. In his new role, Dishman will drive the "strategic and user-centered development of new program features." Dishman, a cancer survivor, said this change would allow him to focus on his long-term health and direct his energies toward patient advocacy activities. The shift in leadership also marks an evolution for the All of Us program "from a startup to a more established organization," he noted. A nationwide search for a new director and CEO of the population health research effort will begin this week. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.